Important: New valproate safety and educational materials

New regulatory measures are now in place to reduce the known harms from valproate, including the significant risk of serious harm to the baby if taken during pregnancy and the risk of impaired fertility in males.  For further information and resources please read the article in full by clicking on the link below:

Important: New valproate safety and educational materials (mailchi.mp)

The Medicines and Healthcare products Regulatory Agency (MHRA) have now published materials to support the implementation of these new measures, along with a Drug Safety Update.